Search

Raymond J. Henley Iii

Examiner (ID: 7179, Phone: (571)272-0575 , Office: P/1629 )

Most Active Art Unit
1614
Art Unit(s)
1205, 2899, 1629, 1614, 1621
Total Applications
4324
Issued Applications
3034
Pending Applications
603
Abandoned Applications
710

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4133304 [patent_doc_number] => 06147095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Method for improving the pharmacokinetics of tipranavir' [patent_app_type] => 1 [patent_app_number] => 9/430742 [patent_app_country] => US [patent_app_date] => 1999-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10593 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/147/06147095.pdf [firstpage_image] =>[orig_patent_app_number] => 430742 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/430742
Method for improving the pharmacokinetics of tipranavir Oct 28, 1999 Issued
Array ( [id] => 1533088 [patent_doc_number] => 06410535 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance' [patent_app_type] => B1 [patent_app_number] => 09/427579 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4232 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410535.pdf [firstpage_image] =>[orig_patent_app_number] => 09427579 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/427579
Prophylactic or therapeutic agents for diseases having vascular dysfunction associated with insulin resistance Oct 26, 1999 Issued
Array ( [id] => 4239670 [patent_doc_number] => 06080736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam' [patent_app_type] => 1 [patent_app_number] => 9/429503 [patent_app_country] => US [patent_app_date] => 1999-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 11244 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080736.pdf [firstpage_image] =>[orig_patent_app_number] => 429503 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/429503
Methods and compositions for treating and preventing anxiety and anxiety disorders using optically pure (R) tofisopam Oct 26, 1999 Issued
Array ( [id] => 4401537 [patent_doc_number] => 06231894 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase' [patent_app_type] => 1 [patent_app_number] => 9/421942 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 13 [patent_no_of_words] => 10786 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/231/06231894.pdf [firstpage_image] =>[orig_patent_app_number] => 421942 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/421942
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase Oct 20, 1999 Issued
90/005536 COMPOSITION AND METHOD FOR TREATING ACUTE OR CHRONIC RHINOSINUSITIS Oct 20, 1999 Issued
Array ( [id] => 4143983 [patent_doc_number] => 06031006 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Method of treating diabetic nephropathy' [patent_app_type] => 1 [patent_app_number] => 9/422486 [patent_app_country] => US [patent_app_date] => 1999-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2282 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031006.pdf [firstpage_image] =>[orig_patent_app_number] => 422486 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/422486
Method of treating diabetic nephropathy Oct 20, 1999 Issued
Array ( [id] => 4248180 [patent_doc_number] => 06136807 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-24 [patent_title] => 'Composition for the transdermal delivery of lerisetron' [patent_app_type] => 1 [patent_app_number] => 9/419859 [patent_app_country] => US [patent_app_date] => 1999-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4929 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/136/06136807.pdf [firstpage_image] =>[orig_patent_app_number] => 419859 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/419859
Composition for the transdermal delivery of lerisetron Oct 18, 1999 Issued
Array ( [id] => 4368491 [patent_doc_number] => 06274599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Cisapride extended release' [patent_app_type] => 1 [patent_app_number] => 9/419590 [patent_app_country] => US [patent_app_date] => 1999-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2099 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274599.pdf [firstpage_image] =>[orig_patent_app_number] => 419590 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/419590
Cisapride extended release Oct 17, 1999 Issued
Array ( [id] => 4155958 [patent_doc_number] => 06103695 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Method of producing pleurodesis' [patent_app_type] => 1 [patent_app_number] => 9/416869 [patent_app_country] => US [patent_app_date] => 1999-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10409 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103695.pdf [firstpage_image] =>[orig_patent_app_number] => 416869 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/416869
Method of producing pleurodesis Oct 12, 1999 Issued
Array ( [id] => 4383647 [patent_doc_number] => 06294579 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Method for improving delivery of tyrosine supplementation' [patent_app_type] => 1 [patent_app_number] => 9/415808 [patent_app_country] => US [patent_app_date] => 1999-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2109 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294579.pdf [firstpage_image] =>[orig_patent_app_number] => 415808 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/415808
Method for improving delivery of tyrosine supplementation Oct 10, 1999 Issued
Array ( [id] => 4208529 [patent_doc_number] => 06028095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-22 [patent_title] => 'Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists' [patent_app_type] => 1 [patent_app_number] => 9/416158 [patent_app_country] => US [patent_app_date] => 1999-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2764 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/028/06028095.pdf [firstpage_image] =>[orig_patent_app_number] => 416158 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/416158
Treatment of inflammatory bowel disease using histamine H.sub.3 -receptor agonists Oct 10, 1999 Issued
Array ( [id] => 4215148 [patent_doc_number] => 06039981 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-03-21 [patent_title] => 'Antifungal oral composition containing itraconazole and process for preparing same' [patent_app_type] => 1 [patent_app_number] => 9/411510 [patent_app_country] => US [patent_app_date] => 1999-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2588 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/039/06039981.pdf [firstpage_image] =>[orig_patent_app_number] => 411510 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/411510
Antifungal oral composition containing itraconazole and process for preparing same Oct 3, 1999 Issued
Array ( [id] => 4099625 [patent_doc_number] => 06048886 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-04-11 [patent_title] => 'Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin' [patent_app_type] => 1 [patent_app_number] => 9/409278 [patent_app_country] => US [patent_app_date] => 1999-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6641 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/048/06048886.pdf [firstpage_image] =>[orig_patent_app_number] => 409278 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/409278
Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin Sep 29, 1999 Issued
Array ( [id] => 4350600 [patent_doc_number] => 06214855 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-10 [patent_title] => 'Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds' [patent_app_type] => 1 [patent_app_number] => 9/402084 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9102 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/214/06214855.pdf [firstpage_image] =>[orig_patent_app_number] => 402084 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/402084
Method for the treatment of stroke using N-heterocyclic glyoxlyamide compounds Sep 28, 1999 Issued
Array ( [id] => 4177533 [patent_doc_number] => 06149915 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-21 [patent_title] => 'Treatment of diabetic nephropathy and microalbuminuria' [patent_app_type] => 1 [patent_app_number] => 9/408436 [patent_app_country] => US [patent_app_date] => 1999-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 8 [patent_no_of_words] => 10373 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/149/06149915.pdf [firstpage_image] =>[orig_patent_app_number] => 408436 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/408436
Treatment of diabetic nephropathy and microalbuminuria Sep 28, 1999 Issued
Array ( [id] => 4295880 [patent_doc_number] => 06197788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => '(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders' [patent_app_type] => 1 [patent_app_number] => 9/355205 [patent_app_country] => US [patent_app_date] => 1999-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 6497 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197788.pdf [firstpage_image] =>[orig_patent_app_number] => 355205 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/355205
(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders Sep 26, 1999 Issued
Array ( [id] => 4235511 [patent_doc_number] => 06075028 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-13 [patent_title] => 'Method of treating Tourette\'s syndrome and related CNS disorders' [patent_app_type] => 1 [patent_app_number] => 9/401302 [patent_app_country] => US [patent_app_date] => 1999-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1191 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/075/06075028.pdf [firstpage_image] =>[orig_patent_app_number] => 401302 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/401302
Method of treating Tourette's syndrome and related CNS disorders Sep 22, 1999 Issued
Array ( [id] => 4382883 [patent_doc_number] => 06294533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-25 [patent_title] => 'Calcium channel blockers' [patent_app_type] => 1 [patent_app_number] => 9/401699 [patent_app_country] => US [patent_app_date] => 1999-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6921 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/294/06294533.pdf [firstpage_image] =>[orig_patent_app_number] => 401699 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/401699
Calcium channel blockers Sep 22, 1999 Issued
Array ( [id] => 4119677 [patent_doc_number] => 06071974 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-06 [patent_title] => 'Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation' [patent_app_type] => 1 [patent_app_number] => 9/401057 [patent_app_country] => US [patent_app_date] => 1999-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3131 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/071/06071974.pdf [firstpage_image] =>[orig_patent_app_number] => 401057 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/401057
Limpid parenteral solution of 2,6-diisoprophylphenol as an anaesthetic drug and 2.5-di-O-methyl-1.4;3.6-dianhydro-D-glucitol as a solvent for making clear I. V. formulation Sep 21, 1999 Issued
09/381461 PREVENTIVES FOR RECONSTRICTION Sep 20, 1999 Abandoned
Menu